-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LSpsq+hoX9R40unngUHidRDkdpJK/eZGhgbH/8M3WFNRIlhgbnXNeKE29oa17ZR/ lddE7tRNeqPTVo6oTXQfrQ== 0001005444-98-000020.txt : 19980223 0001005444-98-000020.hdr.sgml : 19980223 ACCESSION NUMBER: 0001005444-98-000020 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19980219 ITEM INFORMATION: FILED AS OF DATE: 19980220 SROS: NONE FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIORELEASE CORP CENTRAL INDEX KEY: 0000797662 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 880218411 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 000-15260 FILM NUMBER: 98546625 BUSINESS ADDRESS: STREET 1: 340 GRANITE STREET STREET 2: SUITE 200 CITY: MANCHESTER STATE: NH ZIP: 03102 BUSINESS PHONE: 6033711255 MAIL ADDRESS: STREET 1: 340 GRANITE STREET STREET 2: SUITE 200 CITY: MANCHESTER STATE: NH ZIP: 13102 FORMER COMPANY: FORMER CONFORMED NAME: OIA INC DATE OF NAME CHANGE: 19920703 8-K 1 CURRENT REPORT FOR BIORELEASE CORP. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report: February 19, 1998 BIORELEASE CORP. --------------------------------------------------------- (Exact name of registrant as specified in charter) Delaware 88-0218411 0-15260 - -------------------------------------------------------------------------------- Jurisdiction of Commission File I.R.S. Employer Incorporation Number Identification Number 340 Granite St., Suite 200, Manchester, NH 03102 ------------------------------------------------ (Address of principal executive offices) Registrant's telephone number: (603) 641-8443 -------------- Item 5. Other Events. BIORELEASE CORP., a publicly owned company (listed on the OTC Bulletin Board: BRLZ), and XENIX RESOURCES, INC., a privately owned Alabama corporation ("Xenix") have signed a definitive agreement for an exchange of shares, pursuant to which BRLZ will acquire XENIX in a reverse acquisition. The currently outstanding BRLZ shares are proposed to be reverse split approximately 1 for 27, resulting in 356,000 post-reverse split shares, and BRLZ will then issue a total of 8,724,000 post-reverse split shares to XENIX's shareholders and others. Prior to closing, BRLZ will sell or otherwise dispose of its interest in its wholly-owned subsidiary, Biorelease Technologies, Inc., in a manner designed to benefit BRLZ shareholders of record as of the record date to be set for approval of the XENIX acquisition. XENIX's management will assume control of BRLZ, which will change its corporate name to XENIX RESOURCES, INC. XENIX, headquartered in Birmingham, Alabama, is a leading supplier of high grade metallurgical coal for industrial use and also produces steam coal for electric generation, for sale to utilities in the southern United States. XENIX's customers, in addition to numerous privately owned coking and industrial cement companies, include Alabama Electric Cooperative, Seminole Electric Cooperative, Gulf Power Company, and Mississippi Power Company. Historically, approximately 70% of XENIX's revenues have been generated from sale of its coking coal used in the production of high grade steel for use in foundries and for the construction of buildings, bridges, etc. XENIX, via its wholly owned subsidiaries, was founded in 1989 by Derrell J. Chamblee, a 30-year veteran of the coal industry. As of and for the nine months ended September 30, 1997, XENIX had total assets of $19.4 million, a net worth of $4.2 million, and nine month revenues and net income of $14.6 million and $1.04 million, respectively (audited). The Board of Directors of BRLZ has named Dr. Bruce Reeves, who was BRLZ's president from 1992 until December 1996, as interim president of BRLZ pending completion of the reverse merger. Completion of the reverse merger is subject to, among other things, shareholder approval by both BRLZ and XENIX, and the filing with the Securities and Exchange Commission, and effectiveness, of a proxy statement/prospectus. Upon completion of the reverse merger, the newly-reorganized company intends to file for a listing on the NASDAQ. SIGNATURES ---------- Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIORELEASE CORP. By: /s/ R. Bruce Reeves ------------------------ R. Bruce Reeves, Interim President Dated: February 19, 1998 -----END PRIVACY-ENHANCED MESSAGE-----